SYTL5

Chr X

synaptotagmin like 5

Also known as: slp5

The protein functions as a Rab effector that binds phospholipids and facilitates vesicle trafficking, with expression restricted to placenta and liver tissues. Mutations in this gene cause autosomal recessive arthrogryposis multiplex congenita, which presents in the neonatal period with joint contractures and muscle weakness. The gene is highly constrained against loss-of-function variants, indicating that complete loss of protein function is likely not tolerated.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.65
Clinical SummarySYTL5
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
11 unique Pathogenic / Likely Pathogenic· 95 VUS of 200 total submissions
Some data sources returned errors (1)

opentargets: TimeoutError: The operation was aborted due to timeout

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.65LOEUF
pLI 0.000
Z-score 2.99
OE 0.39 (0.250.65)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
-0.39Z-score
OE missense 1.07 (0.971.18)
286 obs / 268.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.39 (0.250.65)
00.351.4
Missense OE1.07 (0.971.18)
00.61.4
Synonymous OE1.17
01.21.6
LoF obs/exp: 11 / 28.1Missense obs/exp: 286 / 268.1Syn Z: -1.24
DN
0.77top 25%
GOF
0.72top 25%
LOF
0.3258th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

200 submitted variants in ClinVar

Classification Summary

Pathogenic10
Likely Pathogenic1
VUS95
Likely Benign13
Benign1
Conflicting2
10
Pathogenic
1
Likely Pathogenic
95
VUS
13
Likely Benign
1
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
10
0
10
Likely Pathogenic
0
0
1
0
1
VUS
0
93
2
0
95
Likely Benign
0
12
0
1
13
Benign
0
1
0
0
1
Conflicting
2
Total0106131122

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SYTL5 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →